These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22414579)

  • 1. Systems biology of tumor dormancy: linking biology and mathematics on multiple scales to improve cancer therapy.
    Enderling H; Hahnfeldt P; Hlatky L; Almog N
    Cancer Res; 2012 May; 72(9):2172-5. PubMed ID: 22414579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms underlying tumor dormancy.
    Almog N
    Cancer Lett; 2010 Aug; 294(2):139-46. PubMed ID: 20363069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dormancy and cancer stem cells: An enigma for cancer therapeutic targeting.
    Talukdar S; Bhoopathi P; Emdad L; Das S; Sarkar D; Fisher PB
    Adv Cancer Res; 2019; 141():43-84. PubMed ID: 30691685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The genomic regulation of metastatic dormancy.
    Gelman IH
    Cancer Metastasis Rev; 2023 Mar; 42(1):255-276. PubMed ID: 36600151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell dormancy and tumor refractory.
    Wang K; Jiang W; Cheng C; Li Y; Tu M
    Anticancer Agents Med Chem; 2013 Feb; 13(2):1312-1316. PubMed ID: 22934702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor dormancy, oncogene addiction, cellular senescence, and self-renewal programs.
    Bellovin DI; Das B; Felsher DW
    Adv Exp Med Biol; 2013; 734():91-107. PubMed ID: 23143977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor cell dormancy: an NCI workshop report.
    Vessella RL; Pantel K; Mohla S
    Cancer Biol Ther; 2007 Sep; 6(9):1496-504. PubMed ID: 17881897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An in vitro system to study tumor dormancy and the switch to metastatic growth.
    Barkan D; Green JE
    J Vis Exp; 2011 Aug; (54):. PubMed ID: 21860375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifaceted kinetics of immuno-evasion from tumor dormancy.
    d'Onofrio A
    Adv Exp Med Biol; 2013; 734():111-43. PubMed ID: 23143978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systems biology: confronting the complexity of cancer.
    Gentles AJ; Gallahan D
    Cancer Res; 2011 Sep; 71(18):5961-4. PubMed ID: 21896642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Report on EU-USA workshop: how systems biology can advance cancer research (27 October 2008).
    Aebersold R; Auffray C; Baney E; Barillot E; Brazma A; Brett C; Brunak S; Butte A; Califano A; Celis J; Cufer T; Ferrell J; Galas D; Gallahan D; Gatenby R; Goldbeter A; Hace N; Henney A; Hood L; Iyengar R; Jackson V; Kallioniemi O; Klingmüller U; Kolar P; Kolch W; Kyriakopoulou C; Laplace F; Lehrach H; Marcus F; Matrisian L; Nolan G; Pelkmans L; Potti A; Sander C; Seljak M; Singer D; Sorger P; Stunnenberg H; Superti-Furga G; Uhlen M; Vidal M; Weinstein J; Wigle D; Williams M; Wolkenhauer O; Zhivotovsky B; Zinovyev A; Zupan B
    Mol Oncol; 2009 Feb; 3(1):9-17. PubMed ID: 19383362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inherent premise of immunotherapy for cancer dormancy.
    Manjili MH
    Cancer Res; 2014 Dec; 74(23):6745-9. PubMed ID: 25411346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor dormancy as an alternative step in the development of chemoresistance and metastasis - clinical implications.
    Rossari F; Zucchinetti C; Buda G; Orciuolo E
    Cell Oncol (Dordr); 2020 Apr; 43(2):155-176. PubMed ID: 31392521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controversies in clinical cancer dormancy.
    Uhr JW; Pantel K
    Proc Natl Acad Sci U S A; 2011 Jul; 108(30):12396-400. PubMed ID: 21746894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary and metastatic tumor dormancy as a result of population heterogeneity.
    Kareva I
    Biol Direct; 2016 Aug; 11(1):37. PubMed ID: 27549396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New clinical and experimental approaches for studying tumor dormancy: does tumor dormancy offer a therapeutic target?
    Goss P; Allan AL; Rodenhiser DI; Foster PJ; Chambers AF
    APMIS; 2008; 116(7-8):552-68. PubMed ID: 18834402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dormant disseminated tumor cells and cancer stem/progenitor-like cells: Similarities and opportunities.
    Hen O; Barkan D
    Semin Cancer Biol; 2020 Feb; 60():157-165. PubMed ID: 31491559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast Cancer Dormancy in Bone.
    Clements ME; Johnson RW
    Curr Osteoporos Rep; 2019 Oct; 17(5):353-361. PubMed ID: 31468498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Micrometastatic disease and metastatic outgrowth: clinical issues and experimental approaches.
    McGowan PM; Kirstein JM; Chambers AF
    Future Oncol; 2009 Sep; 5(7):1083-98. PubMed ID: 19792975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The premise of personalized immunotherapy for cancer dormancy.
    Manjili MH
    Oncogene; 2020 May; 39(22):4323-4330. PubMed ID: 32322001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.